Table 2.
Between-group comparison of fireness changes using the fire-heat symptoms scale after specified treatments
| Variable | Change during Week 1 | Change during Week 2 | Change during Week 3 | Change during Week 4 | |
|---|---|---|---|---|---|
| Deficient fire-heat score | A | −0.01±0.03 | −0.03±0.04 | −0.07±0.07 | −0.10±0.09 |
| B | −0.02±0.04 | −0.06±0.05 | −0.09±0.07 | −0.11±0.09 | |
| C | −0.01±0.03 | −0.04±0.04 | −0.07±0.06 | −0.08±0.07 | |
| Excess fire-heat score | A | −0.01±0.04 | −0.05±0.05 | −0.1±0.07 | −0.12±0.09 |
| B | 0.00±0.04 | −0.06±0.05 | −0.09±0.08 | −0.11±0.10 | |
| C | −0.01±0.04 | −0.06±0.07 | −0.09±0.10 | −0.09±0.11 | |
| Total fire-heat score | A | −0.01±0.03 | −0.05±0.05 | −0.09±0.07 | −0.11±0.09 |
| B | 0.00±0.04 | −0.06±0.05 | −0.09±0.07 | −0.11±0.09 | |
| C | −0.01±0.04 | −0.05±0.06 | −0.09±0.09 | −0.09±0.10 | |
KRG, Korean Red Ginseng.
Data are expressed as mean ± standard deviation.
A: participants were given placebo 3.6 g/d; B: participants were given KRG 1.8 g/d; C: participants were given KRG 3.6 g/d.